Tissue-derived tissuegenic implants, and methods of fabricating and using same
US11305035B2 · kind B2 · utility
0Cited by
269References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2018 |
| Grant date | Apr 19, 2022 |
| Priority date | — |
| Expiry date | Jul 27, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides implants containing a plurality of particles containing at least one population of viable cells adherent to and resident in soft tissue matrix or at least one viable population of cells caused to be in contact with the soft tissue matrix; methods of fabricating the implants; and use of the implants in tissue repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.